mProX™ Human ABL1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryBased on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.
Product Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Charlie
Verified Customer
Vivian
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 WASP is downregulated in CML patients and BCR-ABL1-positive cell lines.
Western blot demonstrating WASP expression in cell lines originating from several leukemia subtypes. High amounts of WASP are expressed by BCR-ABL1-negative cell lines, whereas discrete or undetectable WASP is expressed by BCR-ABL1-positive cells. Actin served as a loading regulator.
Ref: Pereira, Welbert O., et al. "BCR-ABL1-induced downregulation of WASP in chronic myeloid leukemia involves epigenetic modification and contributes to malignancy." Cell death & disease 8.10 (2017): e3114-e3114.
Pubmed: 29022901
DOI: 10.1038/cddis.2017.458
Research Highlights
At least one normal ABL1 allele is typically present in leukemias that express constitutively activated mutations of ABL1 tyrosine kinase (BCR-ABL1, TEL-ABL1, NUP214-ABL1).
Dasgupta, Yashodhara, et al. "Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases." Blood, The Journal of the American Society of Hematology 127.17 (2016): 2131-2143.
Pubmed:
26864341
DOI:
10.1182/blood-2015-11-681171
The types of tyrosine kinase-activating lesions that have been found were examined in this review, along with the preclinical and clinical data supporting the use of tyrosine kinase inhibitors in the management of this unique subtype of ALL.
Boer, Judith M., and Monique L. den Boer. "BCR-ABL1-like acute lymphoblastic leukaemia: From bench to bedside." European Journal of Cancer 82 (2017): 203-218.
Pubmed:
28709134
DOI:
10.1016/j.ejca.2017.06.012